Cargando…

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA

OBJECTIVE: Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and the survival outcomes of patients with OS. METHODS: Transcriptome and clinical data of 86 patients with OS were downloaded from The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mingyi, Zheng, Haishi, Xu, Ke, Yuan, Qiling, Aihaiti, Yirixaiti, Cai, Yongsong, Xu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373797/ https://www.ncbi.nlm.nih.gov/pubmed/35967366 http://dx.doi.org/10.3389/fimmu.2022.919231

Ejemplares similares

Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment
por: Yang, Mingyi, et al.
Publicado: (2023)

Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures
por: Yang, Mingyi, et al.
Publicado: (2023)

Identification of the potential regulatory interactions in rheumatoid arthritis through a comprehensive analysis of lncRNA-related ceRNA networks
por: Yang, Mingyi, et al.
Publicado: (2023)

Bioinformatics Analysis Identified the Hub Genes, mRNA–miRNA–lncRNA Axis, and Signaling Pathways Involved in Rheumatoid Arthritis Pathogenesis
por: Yang, Mingyi, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy
por: Cai, Yongsong, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome
por: Zheng, Haishi, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
por: Zhang, Ze, et al.
Publicado: (2022)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis
por: Yin, Chunlin, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer
por: Xu, Qiushi, et al.
Publicado: (2022)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma
por: Lu, Dingyu, et al.
Publicado: (2023)

Cuproptosis regulator-mediated patterns associated with immune inﬁltration features and construction of cuproptosis-related signatures to guide immunotherapy
por: Wang, Gongjun, et al.
Publicado: (2022)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
por: Wang, Weichen, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_plp314jv0gmfj9ipv0k90skf8d